By attaching an ultrasonic sensor to the top of the white cane used by the blind to detect obstacles, Indian engineer Rohan Paul has reduced upper body collisions by 90% among 200 people who tested the device. More than 10,000 Indians now use the smart cane, which costs $50. "People have been trying to put sensors on canes for a very long time, but there was still an unmet need for a low-cost, effective, usable device," Paul, now a postdoctoral fellow at MIT, said. More
@FierceMedDev: ICYMI: Siemens Healthcare CEO: restructured unit 'hungry' for M&A deals. Article | Follow @FierceMedDev
@EmilyWFierce: UPDATED: AZ stokes $45B sales hopes with expanded approval for breast cancer drug Faslodex. More | Follow @EmilyWFierce
> Becton Dickinson ($BDX) has received FDA approval for its BD Totalys MultiProcessor and BD Totalys SlidePrep instruments that further automates cervical cancer screening. More
> Palmaz Scientific, a maker of implantable devices including the Palmaz Stent, has declared Chapter 11 bankruptcy and is seeking strategic partners. More
> Micro-cap Bionik Laboratories ($BNLK) will buy robotic neurorehabilitation company Interactive Motion Technologies in an all-stock deal worth about $24 million. More
Biotech News
@FierceBiotech: Celldex's cancer vaccine Rintega implodes in glioblastoma PhIII. News | Follow @FierceBiotech
@JohnCFierce: AbbVie hands over $595M upfront to partner with Boehringer on PhIII psoriasis drug. Report | Follow @JohnCFierce
> Bristol-Myers prints a pair of 'Golden Tickets' for Cambridge biotech startups. Report
> Europe takes a page from the FDA with new speedy approval program. Story
> Aimmune's peanut allergy drug clears Phase II on the way to a pivotal test. Article
Pharma News
@FiercePharma: Heska's topsy-turvy year ends on a high note as earnings beat estimates. More from FierceAnimalHealth | Follow @FiercePharma
@CarlyHFierce: Victoza comes up big for Novo with key heart-risk lowering data. More | Follow @CarlyHFierce
> How Venezuela's meltdown delivered a mega-hit to Big Pharma: Reuters. Story
> The potential to restrict generics with REMS is growing and it doesn't bode well for biosimilars. More
> Big Pharma wields big influence in Kentucky for restrictive biosimilars law. Article
Pharma Marketing News
> With Allergan's Kybella campaign, Khloé Kardashian follows sister Kim into pharma land. Report
> New privacy-friendly partnership taps consumer data to help pharma target mobile marketing. Item
> J&J, AbbVie swell Imbruvica patient pool with first-line FDA nod in CLL. More
> DTC challenges mount as senators roll out bill to yank tax deduction. Story
> New privacy-friendly partnership taps consumer data to help pharma target mobile marketing. Article
Animal Health News
> Kindred projects increased spending as it preps for first commercial product. Item
> VCA adds 56 veterinary clinics by snapping up $344M stake in Las Vegas chain. Report
> Heska's topsy-turvy year ends on a high note as record earnings beat estimates. More
> Under pressure from activists, In-N-Out Burger jumps on antibiotic-free bandwagon. Story
> Zoetis launches first genomic test for predicting common diseases in Holsteins. Article
Biotech IT News
> Bristol-Myers signs deal to use Veeva tools for regulatory information. News
> U.K. firms team up to develop mental health-tracking wearable devices. Report
> GSK extends business process analytics contract to 2020. Story
> George Church's Veritas starts $999 whole-genome sequencing service. Item
> IPhone-based Parkinson's study shares 6 months of data on 9,500 participants. Article